Nicotine

Nicotine ingestions among young children declined 2015, but nicotine pouch ingestions more than 700% 2020, according to a study published in Pediatrics.

More adults with social disadvantage receiving 8-week vaporized nicotine products vs. nicotine replacement therapy achieved 6-month continuous smoking abstinence at a 7-month follow-up, according to study results.

SAN FRANCISCO — Both nicotine cravings and levels of cotinine significantly fell in adults treated with cytisinicline vs. placebo who failed to fully quit smoking, according to a secondary analysis of the ORCA-3 trial.

Transcranial magnetic stimulation with added symptom provocation was effective compared with sham for both obsessive-compulsive disorder and nicotine addiction, results of a systematic meta-analysis published in JAMA Psychiatry show.

More adults receiving 6- or 12-week cytisinicline vs. placebo achieved smoking abstinence in the last 4 weeks of treatment, according to results published in JAMA Internal Medicine.

Teenagers and young adults vaping daily/near daily with a desire to quit had better abstinence when treated with 12-week varenicline vs. placebo, according to results published in JAMA.

Nicotine pouches are the latest tobacco trend physicians need to know about, and they should adjust screening methods accordingly, according to experts.

Adolescents in the United States with symptoms of ADHD had a higher likelihood of using tobacco and other nicotine-based products, results from a cohort study published in JAMA Network Open showed.

In this edition, combination extends survival vs. standard first-line therapy, integrated care for smoking cessation during lung cancer screening and more.

The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs. cigarettes and other tobacco products.